Tal Zvi Zaks - 04 Nov 2021 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Director
Signature
/s/ Dov Bergwerk as attorney-in-fact for Tal Zvi Zaks
Issuer symbol
TEVA
Transactions as of
04 Nov 2021
Net transactions value
$0
Form type
4
Filing time
08 Nov 2021, 15:02:08 UTC
Previous filing
04 Oct 2021
Next filing
10 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +12,205 $0.000000 12,205 04 Nov 2021 Ordinary Shares 12,205 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on November 4, 2021 and vest on November 4, 2022.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.